RXSIGHT INC's ticker is and the CUSIP is 78349D107. A total of 115 filers reported holding RXSIGHT INC in Q2 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,294,306 | +11.0% | 655,945 | +14.6% | 0.05% | +8.2% |
| Q2 2023 | $16,486,358 | +183.9% | 572,443 | +64.4% | 0.05% | +172.2% |
| Q1 2023 | $5,807,442 | +77.9% | 348,168 | +35.1% | 0.02% | +63.6% |
| Q4 2022 | $3,265,059 | +14.5% | 257,700 | +8.4% | 0.01% | 0.0% |
| Q3 2022 | $2,852,000 | +1214.3% | 237,641 | +1257.9% | 0.01% | +1000.0% |
| Q1 2022 | $217,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Divisadero Street Capital Management, LP | 680,000 | $18,965,200 | 5.98% |
| NEXT CENTURY GROWTH INVESTORS LLC | 747,827 | $20,856,895 | 2.27% |
| Parkman Healthcare Partners LLC | 381,331 | $10,635,322 | 1.95% |
| Atika Capital Management LLC | 509,352 | $14,205,828 | 1.86% |
| RA Capital Management | 3,052,796 | $85,142,480 | 1.68% |
| EAM Investors, LLC | 163,168 | $4,550,756 | 0.88% |
| No Street GP LP | 250,000 | $6,972,500 | 0.83% |
| ADVISORY RESEARCH INC | 156,189 | $4,356,112 | 0.60% |
| Lisanti Capital Growth, LLC | 123,205 | $3,436,187 | 0.54% |
| Alpha DNA Investment Management LLC | 20,879 | $582,315 | 0.24% |